Regeneron Pharmaceuticals (REGN)
Net Income
$4.82B
TTM · Period ending: · USD
REGN Net Income
Latest reported$4.82Bperiod ending
Latest reported$4.82Bperiod ending
REGN TTM Net Income (-$3.30M → $4.82B)
TTM net income
High-resolution chart · PNG
REGN net income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Net Income (USD) |
|---|---|
| -57,541,000 | |
| -40,821,000 | |
| -28,934,000 | |
| -23,215,000 | |
| -14,876,000 | |
| -16,565,000 | |
| -21,418,000 | |
| -23,000,000 | |
| -27,100,000 | |
| -23,600,000 | |
| -13,700,000 | |
| -8,600,000 | |
| -2,600,000 | |
| -3,100,000 | |
| -9,500,000 | |
| -11,600,000 | |
| -20,200,000 | |
| -27,200,000 | |
| -30,500,000 | |
| -32,400,000 | |
| -32,100,000 | |
| -30,300,000 | |
| -27,100,000 | |
| -23,500,000 | |
| -21,500,000 | |
| -18,400,000 | |
| -24,200,000 | |
| -30,700,000 | |
| -36,400,000 | |
| -42,000,000 | |
| -41,200,000 | |
| -39,800,000 | |
| -34,700,000 | |
| -30,900,000 | |
| -25,200,000 | |
| -19,200,000 | |
| -14,900,000 | |
| -10,000,000 | |
| -6,600,000 | |
| -4,400,000 | |
| -3,200,000 | |
| -3,100,000 | |
| -3,600,000 | |
| -3,300,000 |